Orchard Therapeutics is a biotechnology company based in Menlo Park, CA, dedicated to developing innovative gene therapies for severe genetic diseases. With a focus on HSC gene therapy, their platform has the potential to transform the lives of individuals living with various genetic conditions, including metachromatic leukodystrophy. By building on decades of research, Orchard Therapeutics aims to pioneer groundbreaking treatments that address significant medical needs and provide distinct therapeutic advantages.
Driven by a mission to change the treatment paradigm, Orchard Therapeutics is committed to making a lasting impact on patients and their families. Through their dedication to pioneering science and continuous development, they strive to unlock the limitless possibilities of gene therapy, offering hope and inspiration to those affected by severe genetic diseases.
Generated from the website